Patent Assignment
Reel/Frame 050811/0404
Assignment of Assignor's Interest
Recorded: 2019-10-24
Pages: 62
Assignors
RATIOPHARM GMBH
Executed: 2018-04-16
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Executed: 2018-04-16
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Executed: 2018-04-16
Assignee
89BIO LTD.
6 HAMADA STREET, 4TH FLOOR, HERZLIYA, ISRAEL
Covered Property
(1)
Remodeling and glycopegylation of fibroblast growth factor (FGF)
Application:
60/623,342 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 15, 2005
From: DEFREES, SHAWN
To: NEOSE TECHNOLOGIES, INC.
Reel/Frame 016291/0095 →
Assignment of Assignor's Interest
Aug 21, 2019
From: RATIOPHARM GMBH; TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.
To: 89BIO LTD.
Reel/Frame 050112/0408 →
Corrective Assignment to Correct the Application Number 62/623342 Previously Recorded on Reel 050112 Frame 0408. Assignor(S) Hereby Confirms the License Assignment.
Oct 24, 2019
From: RATIOPHARM GMBH; TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.
To: 89BIO LTD.
Reel/Frame 050817/0001 →
Assignment of Assignor's Interest
Oct 6, 2025
From: 89BIO LTD.
To: 89BIO, INC.
Reel/Frame 072478/0305 →